Tilray Financials

TLRY Stock  USD 1.34  0.03  2.19%   
Based on the key measurements obtained from Tilray's financial statements, Tilray Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Tilray's Non Currrent Assets Other are fairly stable compared to the past year. Inventory is likely to rise to about 264.7 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 82.9 M in 2024. Key indicators impacting Tilray's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.08880.0935
Notably Down
Pretty Stable
Current Ratio27.052.2653
Way Up
Pretty Stable
The essential information of the day-to-day investment outlook for Tilray includes many different criteria found on its balance sheet. An individual investor should monitor Tilray's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tilray.

Net Income

(257.23 Million)

  
Understanding current and past Tilray Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tilray's financial statements are interrelated, with each one affecting the others. For example, an increase in Tilray's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Tilray's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tilray Inc. Check Tilray's Beneish M Score to see the likelihood of Tilray's management manipulating its earnings.

Tilray Stock Summary

Tilray competes with Crinetics Pharmaceuticals, Enanta Pharmaceuticals, Amicus Therapeutics, Connect Biopharma, and Ligand Pharmaceuticals. Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. Tilray Brands is traded on NASDAQ Exchange in the United States.
Foreign Associate
  Canada
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS88688T1007
CUSIP88688T100
LocationBritish Columbia; Canada
Business Address265 Talbot Street
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.tilray.com
Phone844 845 7291
CurrencyUSD - US Dollar

Tilray Key Financial Ratios

Tilray Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets1.8B6.0B5.4B4.3B4.2B4.4B
Other Current Liab4.6M279.2M112.9M123.0M150.7M82.9M
Net Debt(58.1M)450.2M207.9M383.5M159.0M85.9M
Retained Earnings(44.1M)(486.1M)(962.9M)(2.4B)(2.7B)(2.5B)
Cash358.5M488.5M415.9M206.6M228.3M189.1M
Net Receivables50.8M89.8M95.3M86.2M101.7M106.8M
Other Current Assets51.4M48.9M46.8M37.7M63.4M66.6M
Total Liab475.9M1.6B1.0B977.3M778.5M462.5M
Total Current Assets651.2M883.6M803.5M773.0M677.7M396.4M
Common Stock1.3B46K53K66K83K78.9K
Accounts Payable110.1M57.7M68.6M70.8M105.4M110.7M
Inventory190.6M256.4M245.5M200.6M252.1M264.7M
Intangible Assets261.7M1.6B1.3B973.8M915.5M550.5M
Good Will445.5M2.8B2.6B2.0B2.0B1.3B
Short Term Debt7.4M49.6M92.6M224.3M39.0M57.9M

Tilray Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
201920202021202220232024 (projected)
Interest Expense24.8M30.9M39.7M13.6M49.3M51.7M
Operating Income51.5M(4.9M)153.3M(1.4B)(174.7M)(183.5M)
Ebit51.5M(253.6M)(361.6M)(1.0B)(199.8M)(209.7M)
Ebitda67.2M(218.4M)(246.4M)(889.5M)(72.8M)(76.5M)
Income Before Tax(58.2M)(345.0M)(440.7M)(1.5B)(249.0M)(261.5M)
Net Income(61.0M)(336.0M)(434.1M)(1.4B)(245.0M)(257.2M)
Total Revenue391.0M513.1M628.4M627.1M788.9M828.4M
Gross Profit137.7M123.2M116.8M147.0M223.4M234.5M
Research Development1.9M830K1.5M682K635K826.6K
Cost Of Revenue253.3M389.9M511.6M480.2M565.6M593.9M
Income Tax Expense2.8M(9.0M)(6.5M)(7.2M)(26.6M)(25.3M)

Tilray Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Tilray Inc. It measures of how well Tilray is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Tilray brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Tilray had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Tilray has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change In Cash(38.6M)127.8M(72.6M)(209.3M)21.7M15.7M
Free Cash Flow(191.9M)(83.6M)(211.3M)(12.9M)(60.2M)(63.2M)
Capital Expenditures95.5M38.9M34.1M20.8M29.2M54.5M
Net Income(61.0M)(336.0M)(434.1M)(1.4B)(222.4M)(233.5M)
End Period Cash Flow358.5M488.5M415.9M206.6M228.3M204.3M
Other Non Cash Items(2.2M)281.9M185.6M1.3B112.3M178.6M
Change To Inventory(90.3M)(35.3M)(45.7M)(12.9M)(15.6M)(16.4M)
Depreciation35.5M67.8M154.6M130.1M126.9M133.3M

Tilray Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tilray's current stock value. Our valuation model uses many indicators to compare Tilray value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tilray competition to find correlations between indicators driving Tilray's intrinsic value. More Info.
Tilray Inc is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Tilray's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tilray's earnings, one of the primary drivers of an investment's value.

Tilray Inc Systematic Risk

Tilray's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tilray volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Tilray Inc correlated with the market. If Beta is less than 0 Tilray generally moves in the opposite direction as compared to the market. If Tilray Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tilray Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tilray is generally in the same direction as the market. If Beta > 1 Tilray moves generally in the same direction as, but more than the movement of the benchmark.

Tilray Thematic Clasifications

Tilray Inc is part of Cannabis investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Companies involved in production or distribution of medical cannabis. Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally
CannabisView
This theme covers Companies involved in production or distribution of medical cannabis. Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. Get More Thematic Ideas
Today, most investors in Tilray Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tilray's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tilray growth as a starting point in their analysis.

Price Earnings To Growth Ratio

27.71

At this time, Tilray's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Tilray November 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Tilray help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tilray Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tilray Inc based on widely used predictive technical indicators. In general, we focus on analyzing Tilray Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tilray's daily price indicators and compare them against related drivers.

Additional Tools for Tilray Stock Analysis

When running Tilray's price analysis, check to measure Tilray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tilray is operating at the current time. Most of Tilray's value examination focuses on studying past and present price action to predict the probability of Tilray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tilray's price. Additionally, you may evaluate how the addition of Tilray to your portfolios can decrease your overall portfolio volatility.